ASIF420 has been granted by the Kingdom of Lesotho, a medical production licence covering two facilities in the country, including 30,000 sqm. of GAP greenhouses and 20,000 sqm. of EU-GMP packaging facility

With full licensed growing, producing, handeling and exporting medical grade cannabis ,ASIF420 will quickly established itself as an international producer. High efficiency hybrid greenhouses, including those at WeGROW Lesotho represent approximately 80% of the current Company’s production platform.

ASIF420 plans to establish a cultivation hub for medical grade cannabis products

For years, ASIF420 has taken the long-view, leveraging its substantial data position to lay the foundation for a global, revenue-generating network of cannabis ventures. These latest milestones, from world-wide land acquisitions and partnerships, facility developments, licence accreditations, crop cultivation – and sales – validate the Company’s efforts and strategic investments, strengthening its position as the global player, poised to capitalize on emerging markets.

The Company continues to pursue a large and diversified production platform in order to build a sustainable source of supply of high quality cannabis products that can be used for medical and recreational markets. This licensing milestone is a meaningful increase to ASIF420’s capacity but more licensed capacity, currently in the regulatory licensing process, is needed in order to fill the available demand projected in the market.